Pulse Biosciences discloses Co-Chairmen Robert Duggan and CEO Paul LaViolette bought 675,233 shares for ~$13.3M via at-the-market equity program
https://finviz.com/quote?t=PLSE&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.